The progression equation used for HbA1c in the present study, based on 20-year-old data from the UKPDS, could be seen as a limitation, as these data may no longer be representative of modern clinical practice
Pinton P, Giorgi C, Siviero R, Zecchini E, Rizzuto R
Tirzepatide contributed 48,649 more life-years gained per 100,000 people, and semaglutide generated 35,634 more life-years gained per 100,000 people than lifestyle intervention alone
Furthermore, speaking of bioavailability, it is interesting to consider the data that seem to suggest a more efficient absorption of the acetylated form
Joseph's victory over his own weight problems that inspired him to open Skinny Me Med, a clinic devoted to medical approaches to weight management